July 10, 2024

National Institutes of Health Awards $31.7 Million to UAMS Translational Research Institute

David Robinson

UAMS Chancellor Cam Patterson, M.D., MBA, announced the UAMS Translational Research Institute's Clinical and Translational Science Award during a news conference Wednesday.

The University of Arkansas for Medical Sciences (UAMS) Translational Research Institute announced today that it will receive $31.7 million to continue its role in a national effort to accelerate discoveries for the toughest health challenges facing Arkansans and people across the United States. The funding by the National Center for Advancing Translational Sciences (NCATS) at the National…


July 3, 2024

BioVentures Grant Now Aiding Efforts of 25 Health Care and Health Tech Entrepreneurs

David Robinson

BioVentures at UAMS and The Venture Center kicked off the inaugural Arkansas Collaborative for Technological and Innovative Venture Equality (ACTIVE) program on June 20. It included 25 Arkansas health care and health tech companies from across the state.

BioVentures LLC at UAMS and The Venture Center recently announced 25 Arkansas health care and health tech companies from across Arkansas as participants in the new Arkansas Collaborative for Technological and Innovative Venture Equality (ACTIVE) program. The participating companies, led by socially and economically disadvantaged individuals with innovative, early-stage health care and health technology ventures,…


June 14, 2024

Breakthrough Device Implant at UAMS Restores Young Woman’s Pain-Free Life

David Robinson

Jolee Camp, here on her parents' farm, is grateful for having access to a cutting-edge device study at UAMS that has cured her disabling back condition.

Jolee Camp was a thriving 15-year-old who dreamed of becoming a professional dancer and enjoyed hunting, fishing and working on her family’s farm in Lonoke when she was suddenly disabled by unexplained low back pain. “She spent her senior year in a wheelchair,” said her mother, B.J. Camp, who took her daughter from doctor to…


June 6, 2024

Grants Illustrate Impact of UAMS Research Center at UAMS Showcase of Medical Discoveries

David Robinson

Mark Smeltzer, Ph.D., welcomes attendees to the UAMS Showcase of Medical Discoveries.

The recent UAMS Showcase of Medical Discoveries featuring the UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses was a bad news/great news event for Mark Smeltzer, Ph.D., who leads the center. Smeltzer’s Showcase poster, an overview of the center’s achievements since its 2012 inception, included an impressive list of grant awards by 20 individual…


May 9, 2024

UAMS’ Holly Maples, Pharm.D., Recognized by National Society for Effort to Improve Antibiotic Utilization in Pediatric UTIs

David Robinson

Holly Maples, Pharm.D., presented her award-winning poster at the Society for Healthcare Epidemiology of America Spring 2024 Conference.

Holly Maples, Pharm.D., an associate professor in the UAMS College of Pharmacy, was recently recognized by the Society for Healthcare Epidemiology of America for having a top featured poster abstract, which she presented at the society’s Spring 2024 Conference. The recognition stems from her work as a UAMS Translational Research Institute Implementation Science Scholar. The…


April 9, 2024

National Journal Devotes Issue to Project Led by TRI’s Laura James, M.D.

David Robinson

UAMS Translational Research Institute Director Laura James, M.D., led a team of five guest editors from institutions across the United States who were published on their efforts to improve clinical trials.

UAMS Translational Research Institute (TRI) Director Laura James, M.D., concluded her tenure as co-chair of the national Clinical and Translational Sciences Award (CTSA) Steering Committee in December with an effort aimed at making clinical trials more informative and of higher quality. Her work, and those of other CTSA leaders, appears in a themed issue of…


April 4, 2024

NIH Awards UAMS Researchers $2.27 Million to Study Estrogen’s Role in Preventing Bone Loss

David Robinson

UAMS’ Maria Schuller Almeida, Ph.D. (left), and Ha-Neui (Hans) Kim, Ph.D., will use new funding from the National Institutes of Health to answer key questions about estrogen’s important role in preventing bone loss.

LITTLE ROCK — Researchers at the University of Arkansas for Medical Sciences (UAMS) will use a $2.27 million grant from the National Institutes of Health (NIH) to answer key questions about the cellular mechanisms used by estrogen to prevent bone loss and osteoporosis. The five-year NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases…


April 3, 2024

Three UAMS Research Teams Named Inaugural Recipients of BioVentures Accelerator Awards

David Robinson

UAMS’ Gyan Sahukhal, Ph.D., Samir Jenkins, Ph.D., and Mitchell McGill, Ph.D., are the first researchers to receive financial and other support from the new AR Health Ventures Accelerator (ARHVA) program.

BioVentures LLC at UAMS recently announced the selection of three UAMS research teams as the inaugural recipients of its new AR Health Ventures Accelerator (ARHVA) program. The accelerator program, which aims to help jump-start the translation of promising scientific discoveries into therapies, is providing the selected projects with substantial benefits, including financial grants up to…


February 9, 2024

NIH Funds Study of UAMS Nurses’ Influence on Heart Failure Patient Outcomes

David Robinson

Tremaine Williams, Ed.D., at his desk at UAMS.

A University of Arkansas for Medical Sciences (UAMS) research team led by Tremaine Williams, Ed.D., has received a National Institutes of Health (NIH) grant to better understand how nurses influence outcomes of heart failure patients. About 6.2 million people in the United States have heart failure. The two-year, $406,897 R21 grant from the NIH National…


February 6, 2024

UAMS Research Team Discovers Potential Alzheimer’s Drug

David Robinson

UAMS' Sue Griffin, Ph.D., and Meenakshisundaram, Balasubramaniam, Ph.D., led the discovery of the potential Alzheimer's drug for people with the inherited Alzheimer's gene.

LITTLE ROCK — A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D. The findings were published Jan. 8 in Communications Biology and include discoveries of a druggable target and a…



Next page